openPR Logo
Press release

Cell Line Development Market Witness Heightened Revenue Growth with Top Players Lonza Group AG, Sigma-Aldrich, Wuxi App Tec,American Type Culture, Thermo Fisher Scientific

06-15-2019 09:30 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Cell Line Development

Cell Line Development

Cell line is a permanently established cell culture, which proliferates in fresh medium. Cell line development is utilized for examining efficiency of drug discovery and toxicity. It is essential for the production of recombinant proteins production such as, monoclonal antibodies, bi-specific monoclonal antibodies, growth factors, and enzymes using a wide variety of expression systems. Cell lines saves the crucial time, effort and cost by providing the high yield cells which can be used for in vitro testing and reduce chance of research drug to fail in clinical trial stage.

Development of novel therapy to drive growth of the cell line development market

Cell line development has wide application areas. Development of immunotherapy for the treatment of cancer is major application of cell line development. According to the World Health Organization factsheet 2012, cancer is one of the leading cause of death from top three causes of non-communicable disease. Pharmaceutical and biotechnological companies are focusing on developing novel therapies such as immunotherapy due to its specificity and efficiency. Cell line development helps in speeding drug discovery process and optimization of clinical trials by providing high yield of monoclonal antibodies, which is expected to fuel growth of the cell line development market.

Increasing technological advancements in cell line development are expected to boost growth of the cell line development market. For instance, in November 2017, Lonza group launched Multiplex Cell line culture using GS Xceed Gene Expression System., which helps in testing multiple drug candidate at early developmental stage thereby saving four to six months, which otherwise is required in conventional development program.

Request A Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/1286

North America is expected to hold the dominant position in the global cell line development market, owing to high investment by pharmaceutical companies in developing a novel treatment product and increasing off patenting of major products, which would promote biosimilar drug development. Biosimilar drug having biological molecule needs to match in structure and composition with original product which needs cell line to confirm matching of structure and adhere to quality attribute such as glycoprofile, protein aggregation. For instance, according to 2016 report of International Trade Administration of Department of Commerce (USA), the U.S. generic drug sales reached an estimated US$ 70 billion in 2015, which represents quarter of the global market, due to a large number of drugs going off-patent and healthcare reforms favoring generics development. According to the same report, biologics account for over a third of all new drugs in clinical trials or which are waiting for FDA approval. According to Pharmaceutical Research and Manufacturers of America, companies such as Novartis AG, Merck and Company and F. Hoffmann-LA Roche AG in U.S. together invested in US$ 75 billion in research and development. Legal factors such Affordable Care Act which has already covered most of population would boost the usage for novel products as patients can get treated with insurance coverage without out of pocket expenditure on such medication .

Collaborations by cell line development companies with drug discovery companies to speed up expansion of cell line development market

Some of the major players operating in the global cell line development market include Lonza Group AG, Sigma-Aldrich Corporation, Wuxi App Tec, Inc., American Type Culture Collection, Thermo Fisher Scientific, Inc., PX’Therapeutics SA., Selexis SA, GE Healthcare, European Collection of Cell Cultures , Corning, Inc., Sartorious AG, Goodwin Biotechnology Inc., and Cleancells. These companies are entering into strategic partnership with drug discovery companies to optimize their product development:

In December 2017, Selexis SA and Turgut Pharmaceuticals announced to enter into a third commercial license agreement, which would provide Turgut with access to Selexis SUREtechnology Platform and SURE CHO-M Cell Line for the development of biosimilar product for the treatment of two rare diseases such as paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. The companies were already in agreement (made in July 2016) to develop biosimilar products to treat inflammatory diseases and certain cancers using the SURE CHO-M Cell Lines.

In October 2017, Selexis SA and Pelican Therapeutics (subsidiary of Heat Biologics, Inc.) announced to enter into an agreement for the development of Pelican’s immunotherapy clinical candidates PTX-35 and PTX-15. Pelican would utilize Selexis’s SUREtechnology PlatformTM to rapidly develop high-performance research cell banks expressing two of research candidate such as PTX-35, which is humanized monoclonal antibody that is a functional agonist of human TNFRSF25, and PTX-15, which is a human TL1A-Ig fusion protein.

In November 2017, American Type Culture Collection announced the release of an innovative in vitro model system of cell lines for key mechanism of invasion and metastasis in lung cancer
In January 2018, PX’Therapeutics announced collaboration with biotech firm Advaxis for process development of immunotherapies of Advaxis

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1286

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cell Line Development Market Witness Heightened Revenue Growth with Top Players Lonza Group AG, Sigma-Aldrich, Wuxi App Tec,American Type Culture, Thermo Fisher Scientific here

News-ID: 1776623 • Views:

More Releases from Coherent Market Insights

Nutritional Yeast Market is Estimated to Witness High Growth Owing to Rising Health Consciousness Among Consumers
Nutritional Yeast Market is Estimated to Witness High Growth Owing to Rising Hea …
Market Overview: Nutritional yeast is a type of yeast that provides protein and vitamins, especially B-complex vitamins such as riboflavin, niacin, vitamin B6, folate, and vitamin B12. It is commonly used as a flavor enhancer and food ingredient. Nutritional yeast has a cheese-like, nutty, and creamy flavor and is commonly used to replace cheese or add nutritional value to vegan diets. Market Dynamics: The nutritional yeast market is driven by rising health consciousness
Mayonnaise Market is Estimated to Witness High Growth Owing to Rising Healthy Food Consumption
Mayonnaise Market is Estimated to Witness High Growth Owing to Rising Healthy Fo …
Market Overview: Mayonnaise is a thick, creamy sauce made from egg yolks, oil, vinegar or lemon juice, and seasoning. It is used as a dressing or condiment for salads, sandwiches, etc. Mayonnaise comes in varieties for different flavors and uses like low-fat, olive oil-based, flavored, etc. Market Dynamics: The Mayonnaise Market is expected to witness significant growth over the forecast period owing to rising health consciousness among consumers and growing preference for healthy
Dairy Protein Market is Estimated to Witness High Growth Owing to Rising Consumption of Sports Nutrition Products
Dairy Protein Market is Estimated to Witness High Growth Owing to Rising Consump …
Market Overview: Dairy proteins are widely used in various food products like infant formula, sports nutrition, and functional beverages due to their high nutritional value. Whey protein is widely used to manufacture sports drinks for muscle recovery and building post workout. Market Dynamics: The global dairy protein market is expected to witness significant growth over the forecast period owing to rising consumption of sports nutrition products and functional beverages. The growing health-conscious population
Cucumber Seeds Market is Estimated to Witness High Growth Owing to Rising Demand for Organic Food Products
Cucumber Seeds Market is Estimated to Witness High Growth Owing to Rising Demand …
Market Overview: Cucumber seeds are used to grow cucumbers, which are mainly consumed raw in salads or added to sandwiches. They are a rich source of nutrients and add crunch and flavor to meals. Market Dynamics: The cucumber seeds market is expected to witness significant growth over the forecast period owing to rising demand for organic food products. Consumers are increasingly preferring organic foods due to rising health concerns regarding consumption of chemicals

All 5 Releases


More Releases for Cell

Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY
Load Cell Market Key Player Analysis By Single Point Load Cell, Compression Load …
The Load Cell Report consists of all the basic information regarding the Load Cell market. The all-inclusive report will aid users to understand the market current trends, industry growth drivers, share, analysis, size, production, forecast trends, supply, sales, demands, and many other aspects. The analysis was accomplished using an objective amalgamation of primary and secondary data including contributions from major participants in the market. The global Load Cell report is
Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell …
Researchmoz added Most up-to-date research on "Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell, Embryonic Stem Cell & Adult Stem Cell" to its huge collection of research reports. In this report, the global Stem Cell Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between
Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem …
Researchmoz added Most up-to-date research on "Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem Cell Culture, Neural Stem Cell Culture & Mesenchymal Stem Cell Culture" to its huge collection of research reports. In this report, the global Stem Cell Media market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a